blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2585440

EP2585440 - 3-AMINO-5,6-DIHYDRO-1H-PYRAZIN-2-ONE DERIVATIVES USEFUL FOR THE TREATEMENT OF ALZHEIMER'S DISEASE AND OTHER FORMS OF DEMENTIA [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  20.03.2015
Database last updated on 07.10.2024
Most recent event   Tooltip20.03.2015Application deemed to be withdrawnpublished on 22.04.2015  [2015/17]
Applicant(s)For all designated states
Janssen Pharmaceutica, N.V.
Turnhoutseweg 30
2340 Beerse / BE
[2013/18]
Inventor(s)01 / TRABANCO-SUÁREZ, Andrés Avelino
c/o Janssen-Cilag S.A.
Calle Jarama
75 Poligono Industrial
E-45007 Toledo / ES
02 / DELGADO-JIMÉNEZ, Francisca
c/o Janssen-Cilag S.A.
Calle Jarama
75 Poligono Industrial
E-45007 Toledo / ES
03 / TRESADERN, Gary, John
c/o Janssen-Cilag S.A.
Calle Jarama
75 Poligono Industrial
E-45007 Toledo / ES
 [2013/18]
Representative(s)Quaghebeur, Luc
Johnson & Johnson
Patent Law Department
Turnhoutseweg 30
2340 Beerse / BE
[N/P]
Former [2013/18]Quaghebeur, Luc
Janssen Pharmaceutica N.V. Patent Department, Turnhoutseweg 30
2340 Beerse / BE
Application number, filing date11729962.827.06.2011
WO2011EP60712
Priority number, dateEP2010016754228.06.2010         Original published format: EP 10167542
[2013/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012000933
Date:05.01.2012
Language:EN
[2012/01]
Type: A1 Application with search report 
No.:EP2585440
Date:01.05.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 05.01.2012 takes the place of the publication of the European patent application.
[2013/18]
Search report(s)International search report - published on:EP05.01.2012
ClassificationIPC:C07D241/08, C07D401/10, C07D401/12, C07D403/10, A61K31/495, A61P25/28
[2013/18]
CPC:
C07D241/08 (EP,KR,US); A61K31/495 (EP,KR,US); A61P25/16 (EP);
A61P25/28 (EP); A61P3/00 (EP); A61P9/00 (EP);
C07D401/10 (EP,KR,US); C07D401/12 (EP,US); C07D403/10 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/18]
Extension statesBA28.01.2013
ME28.01.2013
TitleGerman:3-AMINO-5,6-DIHYDRO-1H-PYRAZIN-2-ON-DERIVATE ZUR BEHANDLUNG VON MORBUS ALZHEIMER UND ANDEREN FORMEN VON DEMENZ[2013/18]
English:3-AMINO-5,6-DIHYDRO-1H-PYRAZIN-2-ONE DERIVATIVES USEFUL FOR THE TREATEMENT OF ALZHEIMER'S DISEASE AND OTHER FORMS OF DEMENTIA[2013/18]
French:DÉRIVÉS DE 3-AMINO-5,6-DIHYDRO-1H-PYRAZIN-2-ONE UTILES POUR LE TRAITEMENT DE LA MALADIE D'ALZHEIMER ET D'AUTRES FORMES DE DÉMENCE[2013/18]
Entry into regional phase28.01.2013National basic fee paid 
28.01.2013Designation fee(s) paid 
28.01.2013Examination fee paid 
Examination procedure28.01.2013Examination requested  [2013/18]
25.07.2013Amendment by applicant (claims and/or description)
08.07.2014Despatch of a communication from the examining division (Time limit: M04)
19.11.2014Application deemed to be withdrawn, date of legal effect  [2015/17]
16.12.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2015/17]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  08.07.2014
Fees paidRenewal fee
01.07.2013Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.06.201404   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2009097278  (JANSSEN PHARMACEUTICA NV [BE], et al) [A] 1-9 * page 1, paragraph 1 * * page 2; compound (I) * * example - ** claim 22 *;
 [E]WO2011080176  (NOVARTIS AG [CH], et al) [E] 1-9 * page 1, paragraph 1 * * page 2; compound (I) * * page 34, line 21 * * example - *
by applicantWO2005037832
    - KOIKE H ET AL., J BIOCHEM., (1999), vol. 126, pages 235 - 42
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.